OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
Epithalon, Ala-Glu-Asp-Gly (AEDG). Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: limited.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Short course low | 5 mg | daily ×10 days | 0.25 mL | 25 u | 2 doses | |
| Short course std | 10 mg | daily ×10 days | 0.5 mL | 50 u | 1 doses | |
| Extended course | 5 mg | daily ×20 days, 2×/yr | 0.25 mL | 25 u | 2 doses |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 5 mg | daily | 0.25 mL | 25 u | 14 | 70 mg |
| Week 3 onward per 4 weeks from here on |
10 mg | daily | 0.5 mL | 50 u | 28 | 280 mg |
A synthetic tetrapeptide from the Khavinson bioregulator programme, associated with telomerase activation and pineal regulation claims. The supporting literature is overwhelmingly from a single Russian research group, largely in journals with limited international peer review, and has not been independently replicated at scale.
Buy Epitalonthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
MGF with polyethylene glycol conjugation to extend circulating half-life from minutes to days. Entirely preclinical and community-…
A tripeptide bioregulator directed at neuronal tissue in the Khavinson framework. Evidence base is the same single-programme liter…
Every compound compared in one table: dose range, how often, half-life and evidence tier.